[
  {
    "ts": null,
    "headline": "ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m",
    "summary": "ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, Australia, and China.",
    "url": "https://finnhub.io/api/news?id=9f6f3d5369c7ffa45fd8ee13fc82dfb71ac94c4adb77e940685aee08fc6a7c74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731340862,
      "headline": "ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m",
      "id": 131287892,
      "image": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/11/shutterstock_459097192.jpg",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, Australia, and China.",
      "url": "https://finnhub.io/api/news?id=9f6f3d5369c7ffa45fd8ee13fc82dfb71ac94c4adb77e940685aee08fc6a7c74"
    }
  }
]